Nadine Gretenkort Andersson

Medicine & Life Sciences

1. Adenosine Monophosphate 8%
2. Antibodies 8%
3. Blood Platelets 7%
4. Centers for Disease Control and Prevention (U.S.) 8%
5. Cesarean Section 7%
6. Child 22%
7. Databases 5%
8. Exons 6%
9. Factor IX 22%
10. Factor VIII 18%
11. Fluorescence 7%
12. Genes 6%
13. Genetic Databases 10%
14. Genetic Testing 9%
15. Genomics 7%
16. Guidelines 8%
17. Half-Life 6%
18. Hematology 16%
19. Hemophilia A 100%
20. Hemophilia B 59%
21. Hemorrhage 22%
22. Immune Tolerance 9%
23. Immunoassay 8%
24. Incidence 10%
25. Internationality 10%
26. Intracranial Hemorrhages 26%
27. Intracranial Sinus Thrombosis 10%
28. Joints 5%
29. Light 5%
30. Low Molecular Weight Heparin 7%
31. Medical Genetics 10%
32. Multicenter Studies 10%
33. Mutation 5%
34. Neutralizing Antibodies 8%
35. Pediatrics 15%
36. Platelet Activation 8%
37. Practice Management 9%
38. Precursor Cell Lymphoblastic Leukemia-Lymphoma 30%
39. Prospective Studies 5%
40. Quality of Life 5%
41. Registries 14%
42. Scandinavian and Nordic Countries 34%
43. Terminology 5%
44. Therapeutics 7%
45. Thrombocytopenia 5%
46. Thromboembolism 13%
47. Thrombosis 8%
48. Venous Thrombosis 7%
49. Whole Exome Sequencing 9%
50. Young Adult 6%